Skip to Main Content

Paper Details

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
Lancet Oncol
297
2020
COVID-19, cancer, cancers, coronavirus 2, patient, patients, severe acute respiratory syndrome, stage I-III cancer, tumour
Author NameAffiliation
David NicolDivision of Clinical Studies, Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Elio RiboliSchool of Public Health, Imperial College London
Charles SwantonThe Francis Crick Institute, University College London Cancer Institute
Mark LawlerQueen's University Belfast
Clare TurnbullInstitute of Cancer Research, Royal Marsden NHS Foundation Trust
  • 1 - 5

Datasets